MetaADEDB 2.0 @ LMMD
Terbutaline
(KFVSLSTULZVNPG-UHFFFAOYSA-N)
Structure
SMILES
OS(=O)(=O)O.OC(c1cc(O)cc(c1)O)CNC(C)(C)C.OC(c1cc(O)cc(c1)O)CNC(C)(C)C
Molecular Formula:
C24H40N2O10S
Molecular Weight:
548.647
Log P:
4.2484
Hydrogen Bond Acceptor:
12
Hydrogen Bond Donor:
10
TPSA:
228.42
CAS Number(s):
23031-32-5
Synonym(s)
1.
Terbutaline
2.
Arubendol
3.
Asthmoprotect
4.
Brethaire
5.
Brethine
6.
Bricanyl
7.
Bricanyl SA
8.
Butaliret
9.
Butalitab
10.
Contimit
11.
KWD-2019
12.
Monovent
13.
Taziken
14.
Tedipulmo
15.
Terbasmin
16.
Terbul
17.
Terbutalin AL
18.
Terbutalin Stada
19.
Terbutalin-ratiopharm
20.
Terbutaline Sulfate
21.
Terbuturmant
22.
terbutalin von ct
23.
KWD 2019
24.
KWD2019
25.
Terbutalin ratiopharm
External Link(s)
MeSHD013726
PubChem Compound31620
441334
ChEBI9450
CHEMBLCHEMBL1315867
KEGGdr:D00688
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug exposure during pregnancyFAERS: 12US FAERS
2AsthmaFAERS: 3
Canada Vigilance: 1		Canada Vigilance
US FAERS
3PalpitationsFAERS: 3US FAERS
4BronchospasmFAERS: 2US FAERS
5Chest discomfortFAERS: 2US FAERS
6DizzinessFAERS: 2US FAERS
7Drug ineffectiveFAERS: 2
Canada Vigilance: 18		Canada Vigilance
US FAERS
8HypotensionFAERS: 2US FAERS
9NauseaFAERS: 2US FAERS
10PneumoniaFAERS: 2US FAERS
11RestlessnessFAERS: 2US FAERS
12Troponin increasedFAERS: 2US FAERS
13AnxietyFAERS: 1US FAERS
14Aortic AneurysmFAERS: 1US FAERS
15Back disorderFAERS: 1US FAERS
16BradycardiaFAERS: 1US FAERS
17Cardiac ArrestFAERS: 1US FAERS
18Cerebral atrophyFAERS: 1US FAERS
19Cerebral disorderFAERS: 1US FAERS
20Chest PainFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
21Complications of maternal exposure to therapeutic drugsFAERS: 1US FAERS
22CystoceleFAERS: 1US FAERS
23DisorientationFAERS: 1US FAERS
24Enamel anomalyFAERS: 1US FAERS
25EosinophiliaFAERS: 1US FAERS
26Erythema InfectiosumFAERS: 1US FAERS
27Feeling abnormalFAERS: 1US FAERS
28Feeling jitteryFAERS: 1US FAERS
29Flat affectFAERS: 1US FAERS
30HeadacheFAERS: 1US FAERS
31HyperacusisFAERS: 1US FAERS
32IncoherentFAERS: 1US FAERS
33Intentional self-injuryFAERS: 1US FAERS
34Medication ErrorFAERS: 1US FAERS
35Myocardial InfarctionFAERS: 1US FAERS
36Neonatal disorderFAERS: 1US FAERS
37Paraesthesia of genital femaleFAERS: 1US FAERS
38Periventricular Nodular HeterotopiaFAERS: 1US FAERS
39PoisoningFAERS: 1US FAERS
40Pre-EclampsiaFAERS: 1US FAERS
41RectoceleFAERS: 1US FAERS
42Respiratory arrestFAERS: 1US FAERS
43ScreamingFAERS: 1US FAERS
44StillbirthFAERS: 1US FAERS
45UrticariaFAERS: 1US FAERS
46Visual disturbanceFAERS: 1US FAERS
47VomitingFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
48Device malfunctionCanada Vigilance: 4Canada Vigilance
49DysphoniaCanada Vigilance: 1Canada Vigilance
50FatigueCanada Vigilance: 1Canada Vigilance
51Intentional product misuseCanada Vigilance: 1Canada Vigilance
52Product complaintCanada Vigilance: 3Canada Vigilance
53Product container issueCanada Vigilance: 1Canada Vigilance
54Product lot number issueCanada Vigilance: 1Canada Vigilance
55Product quality issueCanada Vigilance: 5Canada Vigilance
56Product storage errorCanada Vigilance: 1Canada Vigilance
57Product taste abnormalCanada Vigilance: 1Canada Vigilance
58TremorCanada Vigilance: 1Canada Vigilance
59WheezingCanada Vigilance: 1Canada Vigilance
60Wrong technique in device usage processCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.